Nedisertib
Nedisertib Uses, Dosage, Side Effects, Food Interaction and all others data.
Nedisertib is under investigation in clinical trial NCT03770689 (Study of M3814 in Combination With Capecitabine and Radiotherapy in Rectal Cancer).
| Trade Name | Nedisertib |
| Generic | Nedisertib |
| Type | |
| Formula | C24H21ClFN5O3 |
| Weight | Average: 481.91 Monoisotopic: 481.1316954 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Nedisertib
